【摘要】 目的观察肝动脉化疗栓塞联合无水乙醇注射治疗中晚期肝癌的疗效。方法对23例中、晚期肝癌均先采用肝动脉化疗栓塞术,术后1~2周在CT引导下经皮肝穿刺瘤内注射无水乙醇2~5次。结果肿瘤体积缩小50%以上占30.4%(7/23),小于50%占47.8%(11/23)。AFP降至正常占34.8%(8/23),下降占52.2%(12/23)。1、2、3年生存率分别为69.6%(16/23)、52.2%(12/23)、21.7%(5/23)。结论肝动脉化疗栓塞联合无水乙醇注射是治疗中晚期肝癌的一种安全有效的综合治疗方法。更多还原

【Abstract】 Objective To observe the clinical therapeutic effect of transcatheter arterial chemoembolization(TACE) and percutaneous ethanol injection(PEI) in moderate or advanced liver cancer.Methods For twenty-three cases with moderate or advanced liver cancer,transcatheter arterial chemoembolization was used,and after 1-2 weeks,percutaneous ethanol injection was done for 2-5 times by CT.Results 7 cases(30.4%) showed atrophy>50%,11 cases(47.8%) showed atrophy<50%;AFP returned to normal in 8 cases,and in 12 cases(52.2%) AFP decreased remarkably.The 1-,2-,3-year survival rates were 69.6%(16/23),52.2%(12/23),21.7%(5/23).Conclusions Moderate or advanced liver cancer treated with TACE+ PEI is a safe and efficient method.更多还原